Blaize stock plunges 12% on fraud allegations from Pelican Way
businesssuntimes.com · post 62388 · 2026-07-11
Allegations Trigger Market Reaction
Pelican Way Research, a firm known for publishing investigative reports on publicly traded companies, released a document on or around April 28, 2026, alleging that a business arrangement between Blaize Holdings, Inc. and NeoTensr was fraudulent. Investing.com covered the claims the same day. The market response was immediate: Blaize’s stock price fell 12 percent on the news, delivering a real financial loss to shareholders who had bought shares before the report.
The allegations target the legitimacy of a $50 million deal that had been presented to the investing public as a significant business arrangement. Short sellers profit when a stock falls, and their research reports often scrutinize corporate claims that other investors may have accepted at face value. In this case, the short seller’s challenge struck at the heart of a transaction that Blaize had publicly highlighted.
Neither Blaize Holdings nor NeoTensr have issued public comments on the short seller’s allegations since the report was published. The lack of a response has left the market and investors without a direct corporate rebuttal to the claims.
Investigation into Corporate Disclosures
The Rosen Law Firm, a plaintiff-focused legal practice, has confirmed it is investigating whether Blaize Holdings, Inc. issued materially misleading business information to the investing public. At the center of the probe is the authenticity and completeness of the company’s disclosures regarding the $50 million deal with NeoTensr. The firm is examining the information Blaize provided to the public about the transaction’s legitimacy, focusing on whether statements made to investors were accurate or if they omitted key details.
For investors who purchased Blaize shares, the 12 percent drop represents a tangible financial hit. The investigation will determine whether those losses stem from incomplete or inaccurate disclosures about the NeoTensr partnership. If material discrepancies are found, the case could lead to regulatory scrutiny or investor lawsuits. The Rosen Law Firm has encouraged investors with relevant information to come forward as the investigation continues.
The practice of short selling–betting that a stock will fall–has long been a fixture of financial markets. Short sellers publish research to support their positions, often challenging claims made by public companies about partnerships, revenue, or growth. When such reports question the validity of major business deals, they can prompt formal investigations and legal actions if discrepancies are uncovered.
Context and Market Implications
NeoTensr is a private technology company that specializes in software for artificial intelligence and data processing. Its work centers on tools that help organizations deploy and scale AI models efficiently. The company’s relatively low profile before the allegations added an element of opacity to the announced $50 million deal with Blaize.
This case follows a familiar pattern in financial markets: a public company announces a significant agreement, a short seller disputes its authenticity, and investors react quickly. The outcome of such episodes can affect market trust in corporate disclosures and influence how companies communicate future deals. For regulators, the incident highlights the need for transparent reporting of business arrangements. For investors, it underscores the importance of verifying the substance behind corporate announcements.
The Rosen Law Firm’s investigation is ongoing, and no conclusions have been reached about the accuracy of Blaize’s statements. The episode illustrates the ongoing tension between corporate transparency and the adversarial role that short sellers play in uncovering potential misconduct. As the probe continues, the focus remains on whether the $50 million deal with NeoTensr was a legitimate business arrangement or a misrepresentation that misled the investing public.